search
Back to results

Youth Partners in Care for Suicide Prevention (YPIC-SP)

Primary Purpose

Suicide and Self-harm

Status
Recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
SAFETY-A within usual ED Care
Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts
Sponsored by
University of California, Los Angeles
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Suicide and Self-harm

Eligibility Criteria

15 Years - 24 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age 15-24;
  • past-week suicidal behavior or ideation with plan or intent

Exclusion Criteria:

  • symptoms or illness that precludes informed consent or engagement in study procedures (e.g., active psychosis; drug dependence, no locator information);
  • youth not fluent in English
  • parent not fluent in English or Spanish.

Sites / Locations

  • Ronald Reagan Medical CenterRecruiting
  • Olive View UCLA Education and Research CenterRecruiting
  • Duke UniversityRecruiting
  • Brown UniversityRecruiting
  • University of UtahRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

SAFETY-Acute within Usual ED Care

Combined

Arm Description

The SAFETY-Acute (A) approach to safety planning and stabilization will be integrated within usual ED Care. SAFETY-A was formerly called the Family Intervention for Suicide Prevention, FISP.

The combined treatment arm includes both 1) SAFETY-A integrated within usual ED Care, and 2) therapeutic follow-up contacts using the Coping Long Term with Active Suicidality Program (CLASP) model.

Outcomes

Primary Outcome Measures

Suicide Attempts: Primary Clinical Outcome
suicide attempts fatal, nonfatal, and interrupted
Mental Health Treatment Initiation: Primary Service Use Outcome
initiation of mental health treatment after discharge from ED/hospital

Secondary Outcome Measures

Self-Harm: Secondary Clinical Outcome
Any self-harm including suicidal, nonsuicidal, and ambiguous self-harm
Treatment engagement: Secondary Service Use Outcome
Treatment dose received

Full Information

First Posted
March 11, 2022
Last Updated
November 1, 2022
Sponsor
University of California, Los Angeles
Collaborators
Duke University, Brown University, University of Utah, Olive View-UCLA Education & Research Institute, RAND, Patient-Centered Outcomes Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT05304065
Brief Title
Youth Partners in Care for Suicide Prevention
Acronym
YPIC-SP
Official Title
Youth Partners in Care for Suicide Prevention
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 17, 2022 (Actual)
Primary Completion Date
December 31, 2026 (Anticipated)
Study Completion Date
December 31, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Los Angeles
Collaborators
Duke University, Brown University, University of Utah, Olive View-UCLA Education & Research Institute, RAND, Patient-Centered Outcomes Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 15-24 who present to the Emergency Department (ED) with suicidal ideation or behavior. OUtcomes will be monitored at baseline and at 3, 6 & 12 month follow-up assessments.
Detailed Description
Rationale and Importance of Study: Suicide is currently the second leading cause of death for U.S. youth ages 15-24, responsible for more deaths than any major illness. Youth with serious suicidal behavior or thoughts often present to the nation's Emergency Departments (EDs), particularly youth who make potentially deadly suicide attempts. Evidence is limited regarding optimal interventions for reducing the risk of fatal and nonfatal suicide attempts in these youth, and tested interventions include multiple components. One dimension along which these interventions vary is timing. Some interventions are delivered in the ED, others focus on aftercare, and others combine ED and aftercare interventions. Current evidence supports effectiveness of some interventions for reducing later suicide attempts and improving the likelihood that youth will receive mental health treatment after leaving the ED. However, evidence gaps exist regarding: 1) whether it is sufficient to focus on providing an evidence-based intervention in the ED, or whether a post-ED aftercare intervention is needed to improve youth outcomes; and 2) for which patient subgroups a combined ED and aftercare treatment may be indicated. Answering these questions is vital for guiding resource allocation, as ED care emphasizes care in the ED with limited resources for aftercare. Study Aims: The study addresses this evidence gap by comparing two evidence-based interventions for reducing suicide attempts and improving outcomes for youth presenting to EDs with suicidal episodes: 1) Safety-Acute(A), a crisis therapy session in the ED focused on enhancing safety (previously called Family Intervention for Suicide Prevention, FISP); and 2) SAFETY-A plus the Coping Long-term with Active Suicide Program (CLASP), comprised of brief therapeutic follow-up contacts after discharge from the ED/hospital. Evidence supports benefits of both interventions individually. SAFETY-A/FISP is listed in the National Register of Evidence-Based Practices, and CLASP is being implemented in some Veterans Administration Hospitals. The first aim is to evaluate whether SAFETY-A combined with CLASP aftercare is superior to SAFETY- A alone for reducing the risk of suicide attempts and increasing initiation of follow-up mental health treatment. Second, the investigators examine heterogeneity of treatment effects among subgroups, hypothesizing that in this large diverse sample the strongest benefits of the combined SAFETY-A plus CLASP intervention will be seen in youth who are from ethnic or racial minority groups, socioeconomically disadvantaged, and from rural communities. Third, the investigators aim to increase the value and relevance of the study by engaging patients, parents, family members, providers, and health and mental healthcare system stakeholders in project leadership and activities throughout the study and implement a partnered dissemination plan to enhance the potential for study findings to inform clinical practice and health care delivery. Study Description: The patient population includes 1,516 youth ages 15-24 presenting to EDs with suicidal ideation or behavior in 4 communities across the country selected to include a diverse population (racial, ethnic, rural vs urban, public vs private insurance): California/Los Angeles; North Carolina; Rhode Island; Utah. Youth are randomly assigned to: 1) SAFETY-A; or 2) SAFETY-A plus CLASP. Assessments are conducted at the start of the study and at 3, 6, and 12-month follow-ups. Primary outcomes are suicide attempts and mental health treatment initiation. Secondary outcomes are overall self-harm (including suicide attempts and non-suicidal self-harm) and treatment engagement/dose. Exploratory outcomes are: severity of youth suicidality; youth functioning and quality of life; and improvement on three problems prioritized by the youth and parent or significant other as "top problems." The investigators also examine change in identified protective and risk factors (e.g. connectedness, hopelessness, and perceived barriers to treatment). The investigators partner with diverse stakeholders, develop a Stakeholder Council, and include stakeholder partners in project leadership and activities with the goals of promoting 2-way knowledge exchange and enhancing the value of the study for improving patient care and outcomes. Significance: Study results will clarify whether the additional resources needed to provide brief therapeutic follow-up calls after an ED intervention leads to improved outcomes, and which patient subgroups are most likely to benefit from a treatment approach that provides therapeutic contact both during the ED visit and after discharge from the ED. This information can guide decision makers regarding how to best develop services and service systems to improve patient outcomes and achieve national suicide prevention goals, including for diverse groups to improve equity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Suicide and Self-harm

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Care ProviderOutcomes Assessor
Masking Description
It is not possible to mask intervention condition from participants. Care providers in the ED will be masked to randomized condition. Outcomes assessors will be masked to randomized condition.
Allocation
Randomized
Enrollment
1516 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
SAFETY-Acute within Usual ED Care
Arm Type
Active Comparator
Arm Description
The SAFETY-Acute (A) approach to safety planning and stabilization will be integrated within usual ED Care. SAFETY-A was formerly called the Family Intervention for Suicide Prevention, FISP.
Arm Title
Combined
Arm Type
Active Comparator
Arm Description
The combined treatment arm includes both 1) SAFETY-A integrated within usual ED Care, and 2) therapeutic follow-up contacts using the Coping Long Term with Active Suicidality Program (CLASP) model.
Intervention Type
Behavioral
Intervention Name(s)
SAFETY-A within usual ED Care
Other Intervention Name(s)
Family Intervention for Suicide Prevention (FISP)
Intervention Description
SAFETY-A is a single session collaborative, strengths-based, developmentally nuanced, cognitive-behavioral intervention (CBT) to increase safety and mental health treatment initiation. The therapist works with the youth and family (or significant other, SO) separately and together to build hope and reasons for living, develop a personal safety plan, increase protective supports; and increase motivation for and linkage to treatment.
Intervention Type
Behavioral
Intervention Name(s)
Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts
Intervention Description
COMB, includes SAFETY-A within usual ED care plus CLASP therapeutic and caring follow-up contacts designed to strengthen safety and treatment initiation and engagement. Core functions of CLASP include: building hope/reducing hopelessness; enhancing social/family support; strengthening problem-solving; and increasing treatment initiation and engagement.
Primary Outcome Measure Information:
Title
Suicide Attempts: Primary Clinical Outcome
Description
suicide attempts fatal, nonfatal, and interrupted
Time Frame
Through 12 months of follow-up
Title
Mental Health Treatment Initiation: Primary Service Use Outcome
Description
initiation of mental health treatment after discharge from ED/hospital
Time Frame
Through 12 months of follow-up
Secondary Outcome Measure Information:
Title
Self-Harm: Secondary Clinical Outcome
Description
Any self-harm including suicidal, nonsuicidal, and ambiguous self-harm
Time Frame
Through 12 months of follow-up
Title
Treatment engagement: Secondary Service Use Outcome
Description
Treatment dose received
Time Frame
Through 12 months of follow-up
Other Pre-specified Outcome Measures:
Title
Ordinal suicidality scale: Clinical
Description
Ranges from nonsuicidal through ideation, behavior, attempts, and deaths
Time Frame
Through 12 months of follow-up
Title
Quality of life and functioning: Clinical
Description
PROMIS Global Health Questionnaire , 0-100
Time Frame
Change from baseline through 12 months of follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
24 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age 15-24; past-week suicidal behavior or ideation with plan or intent Exclusion Criteria: symptoms or illness that precludes informed consent or engagement in study procedures (e.g., active psychosis; drug dependence, no locator information); youth not fluent in English parent not fluent in English or Spanish.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lucas Zullo, PhD
Phone
310 794-4962
Email
lzullo@mednet.ucla.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Jocelyn I Meza, PhD
Phone
310 794-4962
Email
jimeza@mednet.ucla.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joan R Asarnow, PhD
Organizational Affiliation
University of California, Los Angeles
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
David Goldston, PhD
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ronald Reagan Medical Center
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095-6968
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joan Asarnow, PhD
Phone
310-794-4962
Email
jasarnow@mednet.ucla.edu
Facility Name
Olive View UCLA Education and Research Center
City
Sylmar
State/Province
California
ZIP/Postal Code
91342
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Naser Ahmadi, MD, Ph.D.
Phone
310-478-3711
Email
nahmadi@mednet.ucla.edu
Facility Name
Duke University
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27708
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
David Goldston, Ph.D.
Email
david.goldston@duke.edu
Facility Name
Brown University
City
Providence
State/Province
Rhode Island
ZIP/Postal Code
02912
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anthony Spirito, Ph.D.
Email
anthony_spirito@brown.edu
Facility Name
University of Utah
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84112
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Brooks Keeshin, MD
Email
brooks.keeshin@hsc.utah.edu

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Decision will be made with PCORI, project investigators, and stakeholders regarding any data sharing. Given relative rarity of suicide attempts it is critical that participant confidentiality be maintained and steps be taken to protect against the possible of unintended loss of anonymity due to focus on rare outcome.
IPD Sharing Time Frame
A limited data set may be available after all data are complete, analyzed, and published. Time frame and plan will be developed by investigators in collaboration with stakeholders and funding agency (PCORI).
IPD Sharing Access Criteria
Decision will be made with PCORI, project investigators, and stakeholders regarding any data access. Given rarity of suicide attempts it is critical that participant confidentiality be maintained and steps be taken to protect against the possibility of unintended loss of anonymity due to focus on rare outcomes.
Links:
URL
http://www.pcori.org/research-results/2021/youth-partners-care-suicide-prevention-ypic-sp
Description
Study description on PCORI site

Learn more about this trial

Youth Partners in Care for Suicide Prevention

We'll reach out to this number within 24 hrs